Principal Investigator
frd43@pitt.edu
Publications
Research Focus
Dr. Dyka is interested in the application of AAV gene therapy in research and clinic. Gene therapy, in which a healthy copy of a gene is delivered to cells or organs, has proven to be a promising approach for the treatment of inherited diseases, specifically for inherited diseases of the retina. Over 200 genes have been identified to cause inherited retinal diseases if mutated, with most currently lacking effective treatment options. The particular focus of his laboratory is to develop novel and improved dual vectors that overcome the limitations of current systems.